News

Elanco has gotten torched over the last six months - since September 2024, its stock price has dropped 28.5% to $10.39 per share. This was partly due to its softer quarterly results and might have investors contemplating their next move.

As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the shelf-stable food industry, including Hain Celestial (NASDAQ:HAIN) and its peers.

The past six months haven’t been great for Select Medical. It just made a new 52-week low of $15.71, and shareholders have lost 55.5% of their capital. This was partly due to its softer quarterly results and might have investors contemplating their next move.

As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the it distribution & solutions industry, including ScanSource (NASDAQ:SCSC) and its peers.

Even during a down period for the markets, Salesforce has gone against the grain, climbing to $274.18. Its shares have yielded a 6.7% return over the last six months, beating the S&P 500 by 8%. This run-up might have investors contemplating their next move.

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Cognex (NASDAQ:CGNX) and the best and worst performers in the specialized technology industry.

Even during a down period for the markets, Compass has gone against the grain, climbing to $8.75. Its shares have yielded a 36.5% return over the last six months, beating the S&P 500 by 37.8%. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.